医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

An Open Letter to Users of Cyclotrons (up to 20 MeV), PETNET, Nuclear Pharmacy & PET/CT for Their Radioisotope Needs

2021年04月28日 AM05:00
このエントリーをはてなブックマークに追加


 

WASHINGTON & OTTAWA, Ontario & NEW DELHI, India

Best ABT, a company of TeamBest Global (TBG) Group, is planning to introduce a new cyclotron — the Best Sub-Compact Model 200 — which can fulfill a hospital’s needs for PET imaging and other similar small cyclotrons. The new cyclotron will have a push-button control and one or more chemistry boxes that can be placed near the PET/CT, eliminating the need to transport radioisotopes from the cyclotron operation to PET/CT locations. The Best Model 200 is self-shielded, with an internal ion source. This is the only such cyclotron in the world. In addition, it can provide the dose in a syringe within 30 minutes with just a touch of a button, while the patient is being set up for PET/CT.

TBG Companies are planning to manufacture a range of diagnostic radiology technologies such as CT, MRI, PET/CT, PET/MRI, X-Ray machines, Ultrasounds, etc. to provide the Best Total Solutions™ for diagnostic radiology and nuclear medicine needs.

The goal of TBG is to make these new technologies possible, affordable and accessible to everyone globally.

For more information about TBG’s range of Cyclotrons, please download the PDF of our upcoming advertisement in CERN Courier at: http://www.bestcyclotron.com/news/CERN_Courier_BCS_BestABT_BPT_MayJune2021.pdf

Click on this link for other news about Best Sub-Compact Model 200 Cyclotron: https://www.einpresswire.com/article/539464246/an-open-letter-to-users-of-cyclotrons-up-to-20-mev-petnet-nuclear-pharmacy-pet-ct-for-their-radioisotope-needs

For more information about Krishnan Suthanthiran, please visit his bio page at http://www.teambest.com/about_bio.html.

For more information about TeamBest Global Companies, Best ABT Molecular Imaging, Best Cyclotron Systems and Best Cure Foundation, please visit:
www.teambest.com
www.bestabt.com
www.bestcyclotron.com
www.bestcure.md

View source version on businesswire.com: https://www.businesswire.com/news/home/20210427006108/en/

CONTACT

Krishnan Suthanthiran • President & Founder

TeamBest Global Companies • Best Cure Foundation

+1 703-451-2378

krish@teambest.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表